RESEARCH-USE BIOSIMILAR ANTIBODY
Azintuxizumab
Antibody-drug conjugate · IgG1
Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.
TARGETSLAMF7
YAntibody-drug conjugate
CATALOGSC-BS-752
CATALOG NUMBERSC-BS-752
MOLECULAR WEIGHTApprox. 145.32 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.
Azintuxizumab is a recombinant research-use antibody directed against SLAMF7.